Momentus says its cash position has jumped to about $76 million with no debt. The real question is whether Vigoride progress can become revenue before share-count math absorbs the upside.
References
Sources used in this report
SEC filing indexSEC company submissions for MomentusRetrieved 2026-06-08 · Latest filing chronology and accession cross-check.SEC XBRL APISEC companyfacts for MomentusRetrieved 2026-06-08 · Filing-derived revenue, loss, cash, operating cash flow and balance-sheet facts.SEC filingMomentus Q1 2026 Form 10-Q2026-05-13 · Q1 financials, Vigoride 7, customer payloads and recent financing context.SEC filingMomentus May 2026 private placement Form 8-K2026-05-29 · $25M private placement, common stock, pre-funded warrants, placement-agent warrants and use of proceeds.SEC filingMomentus Form S-3/A shelf and resale registration2026-06-01 · $200M shelf, resale registration and capital-resources language.Company update via BusinessWire redistributionMomentus June 8 balance-sheet and Vigoride update2026-06-08 · Company-stated $76M cash, no debt, Vigoride 7 progress and Vigoride 8 payload comments.